Subsequently, the authors applied diricore to kidney cancer and invasive breast carcinoma and discovered proline vulnerability and compensatory upregulation of Pyrroline-5-Carboxylate Reductase 1 (PYCR1), which catalyzes the last step in proline biosynthesis [104] (Fig. 3). The gene discussed is PYCR1; the disease is invasive breast carcinoma.